REG - Target Healthcare - Acquisition <Origin Href="QuoteRef">THRLT.L</Origin>

Target Healthcare ReitAnnouncement

28/01/2015 02:49

RNS Number : 2267D
Target Healthcare REIT Limited
27 January 2015
Target Healthcare REIT Limited
RNS Announcement
27 January 2015
Acquisition of Care Home in Swaffham, Norfolk
Target Healthcare REIT Limited and its subsidiaries ("the Group"), a specialist investor in UK care homes, announces that it has acquired a purpose-built care home in Swaffham, Norfolk for approximately 4.5 million including acquisition costs ("the Purchase Price"). This transaction is in accordance with the Group's investment policy.
The home, Iceni House, is a modern two storey property with 74 bedrooms arranged around a central courtyard, each with full en-suite bathrooms with wetroom showers. It is well served with a number of lounges, dining rooms and quiet rooms, as well as a hairdressing salon.
The property has been acquired from Zest Investment Group, and leased to Norfolk Care Homes Limited on an existing 30 year lease with circa 23 years remaining. The Purchase Price represents an initial yield in excess of 7%. The rent payable under the lease is subject to an annual RPI-linked uplift, subject to a cap and collar.
The Group has invested in excess of 142 million (including acquisition costs) in its portfolio of care home assets.
Kenneth MacKenzie, Managing Partner of Target Advisers LLP, commented:
"We are pleased to announce the acquisition of this home, which is the 28th property acquired by the Group. It adds another operator, widening our tenant base, and provides a high quality of care in a welcoming environment. We have a number of other deals in advanced non-binding legal negotiations, and we expect to make further acquisitions in the near future."
All enquiries:
Kenneth MacKenzie
Target Advisers LLP
01786 406 581
Martin Cassels
R&H Fund Services Limited
Mark Young, Roger Clarke, Neil Winward
Oriel Securities Limited
0131 524 6140
020 7710 7600
Fiona Harris / Sam Emery
Quill PR
020 7466 5058 / 020 7466 5056

This information is provided by RNS
The company news service from the London Stock Exchange
  END
ACQPGUMAGUPAURM